Fundz

Brain Mapping Pioneer Omniscient Neurotechnology Raises Aud 40 Million In Series B Financing

PRIVATEJul 19, 2021

Round Type

Series B

SydneyManufacturingBiotechnologyHealthcareHealth CareArtificial IntelligenceMachine Learning

Description

Omniscient Neurotechnology (“o8tTM”), a pioneering brain mapping technology company, today announced the completion of an AUD 40 million Series B financing round. The funding was led by family offices and high-net worth individuals, including Hancock Prospecting’s Executive Chairman Mrs. Gina Rinehart, and prominent fund manager Will Vicars.

Quick answer

Omniscient Neurotechnology raised an undisclosed amount in a Series B round, dated July 19, 2021. Omniscient Neurotechnology is based in Sydney, New South Wales, Australia.

How much did Omniscient Neurotechnology raise?
Omniscient Neurotechnology raised an undisclosed amount in a Series B round on July 19, 2021.
What does Omniscient Neurotechnology do?
Omniscient Neurotechnology (o8t™) is a pioneering brain mapping company that is revolutionizing brain care with data.
Where is Omniscient Neurotechnology based and how big is it?
Omniscient Neurotechnology is based in Sydney, New South Wales, Australia. Fundz records about 54 employees.
Who are the decision-makers at Omniscient Neurotechnology?
Fundz holds 1 contact at Omniscient Neurotechnology. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Manufacturing around the same time

Companies in the same sectors as Omniscient Neurotechnology that raised within 45 days of this round, from Fundz verified event records.

  • Edwards Lifesciences raised $100K (Pre-Seed) on July 27, 2021.
  • Blackford Analysis raised $687K (Seed) on August 20, 2021.
  • Century Therapeutics raised $11M on July 19, 2021.
  • Tenon Medical raised $12M on July 15, 2021.
  • SynerFuse, Inc. raised $275K (Seed) on July 15, 2021.
  • Route 92 Medical raised $47M on July 13, 2021.

Who to call at Omniscient Neurotechnology, and when

A new round usually means Omniscient Neurotechnology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Omniscient Neurotechnology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Omniscient Neurotechnology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Omniscient Neurotechnology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Omniscient Neurotechnology

Location

Sydney, New South Wales, Australia

About

Omniscient Neurotechnology (o8t™) is a pioneering brain mapping company that is revolutionizing brain care with data. Using innovations in medical imaging and machine learning, Omniscient builds applications capable of mapping and analyzing “brain networks” which are formed by the electrical connections within a person’s brain. Such insights are illuminating the neural processes that make us human and helping clinicians and researchers understand, diagnose, and treat complex neurological and mental illnesses. Omniscient is a leader in the field of “connectomics” – the study of the brain’s connections. It recently launched Quicktome™, the world’s first medical device to harness this vital data for neurological care, providing neurosurgeons brain network information prior to life-changing surgery. The company is headquartered in Sydney, Australia with offices globally.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Omniscient Neurotechnology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Omniscient Neurotechnology's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Omniscient Neurotechnology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.